-
2
-
-
1842425722
-
Prevalence of cataract and pseudophakia/aphakia among adults in the United States
-
Congdon N, Vingerling JR, Klein BE, et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol. 2004;122:487-494.
-
(2004)
Arch Ophthalmol
, vol.122
, pp. 487-494
-
-
Congdon, N.1
Vingerling, J.R.2
Klein, B.E.3
-
4
-
-
0022829907
-
The detection and grading of cataract: An epidemiologic perspective
-
West SK, Taylor HR. The detection and grading of cataract: an epidemiologic perspective. Surv Ophthalmol. 1986;31:175-184.
-
(1986)
Surv Ophthalmol
, vol.31
, pp. 175-184
-
-
West, S.K.1
Taylor, H.R.2
-
5
-
-
0025054487
-
Assessment of cataracts from photographs in the Beaver Dam Eye Study
-
Klein BE, Klein R, Linton KL, Magli YL, Neider MW. Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology. 1990;97:1428-1433.
-
(1990)
Ophthalmology
, vol.97
, pp. 1428-1433
-
-
Klein, B.E.1
Klein, R.2
Linton, K.L.3
Magli, Y.L.4
Neider, M.W.5
-
6
-
-
0035133854
-
The agerelated eye disease study (AREDS) system for classifying cataracts from photographs
-
AREDS report No. 4 Age-Related Eye Disease Study Research Group
-
Age-Related Eye Disease Study Research Group. The agerelated eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report No. 4. Am J Ophthalmol. 2001;131:167-175.
-
(2001)
Am J Ophthalmol
, vol.131
, pp. 167-175
-
-
-
7
-
-
84874669710
-
Cataract conversion assessment using lens opacity classification system III and Wisconsin cataract grading system
-
Wong WL, Li X, Li J, et al. Cataract conversion assessment using lens opacity classification system III and Wisconsin cataract grading system. Invest Ophthalmol Vis Sci. 2013;54: 280-287.
-
(2013)
Invest Ophthalmol Vis Sci
, vol.54
, pp. 280-287
-
-
Wong, W.L.1
Li, X.2
Li, J.3
-
8
-
-
0029316799
-
Validation of methods for the assessment of cataract progression in the Roche European- American Anticataract Trial (REACT)
-
Chylack LTJ, Wolfe JK, Friend J, et al. Validation of methods for the assessment of cataract progression in the Roche European- American Anticataract Trial (REACT). Ophthalmic Epidemiol. 1995;2:59-75.
-
(1995)
Ophthalmic Epidemiol
, vol.2
, pp. 59-75
-
-
Chylack, L.T.J.1
Wolfe, J.K.2
Friend, J.3
-
11
-
-
78049235519
-
Evaluation of the agerelated eye disease study clinical lens grading system
-
AREDS report No. 31
-
Chew EY, Kim J, Sperduto RD, et al. Evaluation of the agerelated eye disease study clinical lens grading system AREDS report No. 31. Ophthalmology. 2010;117:2112-2119.
-
(2010)
Ophthalmology
, vol.117
, pp. 2112-2119
-
-
Chew, E.Y.1
Kim, J.2
Sperduto, R.D.3
-
12
-
-
0034788401
-
A randomized, placebo-controlled, clinical trial of high-dose supplementation
-
Age-Related Eye Disease Study Research Group
-
Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation. Arch Ophthalmol. 2001;119:1439-1452.
-
(2001)
Arch Ophthalmol
, vol.119
, pp. 1439-1452
-
-
-
13
-
-
49049118499
-
Brightness, contrast, and color balance of digital versus film retinal images in the age-related eye disease study 2
-
Hubbard LD, Danis RP, Neider MW, et al. Brightness, contrast, and color balance of digital versus film retinal images in the age-related eye disease study 2. Invest Ophthalmol Vis Sci. 2008;49:3269-3282.
-
(2008)
Invest Ophthalmol Vis Sci
, vol.49
, pp. 3269-3282
-
-
Hubbard, L.D.1
Danis, R.P.2
Neider, M.W.3
-
14
-
-
84883638712
-
-
FDA. FDA Guidance for Industry-Standards for Clinical Trial Imaging Endpoints. Rockville, MD: Food and Drug Administration
-
FDA. FDA Guidance for Industry-Standards for Clinical Trial Imaging Endpoints. Rockville, MD: Food and Drug Administration; 2011:1-26.
-
(2011)
, pp. 1-26
-
-
-
15
-
-
84880312820
-
Lutein/zeaxanthin for the treatment of age-related cataract
-
AREDS2 Randomized Trial Report No. 4
-
Chew E, SanGiovanni JP, Ferris FL, et al. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 Randomized Trial Report No. 4. JAMA Ophthalmol. 2013;131:843-850.
-
(2013)
JAMA Ophthalmol
, vol.131
, pp. 843-850
-
-
Chew, E.1
Sangiovanni, J.P.2
Ferris, F.L.3
|